The researchers, led by Jonathan D. F. Wadsworth at University College London, concluded that some persons will be more resistant to vCJD, and that those persons who do get it, will have different symptoms.
Transgenic experiments on mice show that substitution of an aminoacid in the "prion" proteins will produce symptoms different from variant Creutzfeldt-Jakob disease (vCJD), according to the study by British scientists to be published in Science magazine on Friday.
